Anti-inflammatory and anti-invasive effects of α-melanocyte- stimulating hormone in human melanoma cells

British Journal of Cancer

Volumn 89, Issue 10, 2003, Pages 2004-2015

  Eves, P ^a   Haycock, J ^b   Layton, C ^a   Wagner, M ^a   Kemp, H ^a   Szabo, M ^b   Morandini, R ^c   Ghanem, G ^c   Garcia Borron J C ^d   Jimenez Cervantes C ^d   Mac Neil, S ^a,b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

Melanocortin; Melanoma; Metastasis; NF kappaB; MSH

Indexed keywords

ALPHA INTERMEDIN; BETA INTERMEDIN; CALCIUM; CYCLIC AMP; GAMMA INTERMEDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELANOCORTIN 1 RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREGULATION; MELANOMA CELL; METASTASIS POTENTIAL; PLEIOTROPY; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0346752502     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601349     Document Type: Article

References (55)

1. Baumann JB, Bagutti C, Siegrist W, Christen E, Zumsteg U, Eberle A (1997) MSH receptors and the response of human A375 melanoma cells to interleukin-1β. J Recept Signal Transduc Res 17(1-3): 199-210
2. Bohm M, Metze D, Schulte U, Becher E, Luger TA, Brozoska T (1999) Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp Dermatol 8: 453-461
3. Box NF, Wyeth JR, O'Gorman LE, Martin MG, Sturm RA (1997) Characterisation of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Human Mol Genet 269: 1897
4. Bregman MD, Meyskens Jr FL (1983) In vitro modulation of human and murine melanoma growth by prostanoid analogues. Prostaglandins 26: 449-456
5. Buffey J, Thody AJ, Bleehen SS, Mac Neil S (1992) Melanocyte stimulating hormone stimulates protein kinase C activity in murine B16 melanoma. J Endocrinol 133: 333-340
6. Chakrabarty KH, Dawson RA, Harris P, Layton C, Babu M, Gould L, Phillips J, Leigh I, Green C, Freelander E, Mac Neil S (1999) Development of autologous human dermal-epidermal composites based on sterilised human allodermis for clinical use. Br J Dermatol 141: 811-823
7. Chakraborty AK, Funasaka Y, Slominski A, Ermak G, Hwang J, Pawelek JM, Ichihashi M (1996) Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta 1313: 130-138
8. De Luca M, Siegrist W, Bondanza S, Mathor M, Cancedda R, Eberle AN (1993) Melanocyte stimulating hormone (αMSH) stimulates normal human melanocyte growth by binding to high-affinity receptors. J Cell Sci 105: 1079-1084
9. Dewhurst LO, Gee JW, Rennie IG, MacNeil S (1997) Tamoxifen, 17β-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin. Br J Cancer 75(6): 860-868
10. Donatien PD, Hunt G, Pieron C, Lunec J, Taieb A, Thody AJ (1992) The expression of functional MSH receptors on cultured human melanocytes. Arch Dermatol Res 284: 424-426
11. Eberle AN (1988), The Melanotropins: Chemistry, Physiology and Mechanisms of Action. pp 1-439. Basel: Karger
12. Eves P, Layton C, Hedley S, Dawson RA, Wagner M, Morandini R, Ghanem G, Mac Neil S (2000) Characterisation of an in vitro model of human melanoma invasion based on reconstructed human skin. Br J Dermatol 142: 210-222
13. Friedmann PS, Wren F, Buffey J, Mac Neil S (1990) α-MSH causes a small rise in cAMP but has no effect on basal or ultraviolet-stimulated melanogenesis in human melanocytes. Br J Dermatol 123: 145-151
14. Ghanem G, Verstegen J, De Rijcke S, Hanson P, Van Onderbergen A, Libert A, Del Marmol V, Arnould R, Vercammen-Grandjean A, Lejeune F (1989a) Studies on factors influencing human plasma alpha-MSH. Anticancer Res 9(6): 1691-1696
15. Ghanem G, Verstegen J, Libert A, Arnould R, Lejeune F (1989b) Alpha-melanocyte stimulating hormone immunoreactivity in human melanoma metastases extracts. Pigment Cell Res 2(6): 519-523
16. Ghanem GE, Comunale G, Libert A, Vercammen-Grandjean A, Lejeune FJ (1988) Evidence for alpha-melanocyte stimulating hormone (α-MSH) receptors on human malignant melanoma cells. Int J Cancer 41: 248-255
17. Ghosh S, May MJ, Kopp EB (1998) NF-κB and rel proteins: evolutionary conserved mediators of immune responses. Ann Rev Immunol 16: 225-260
18. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP (1973) In vitro cultivation of human tumours: establishment of cell lines derived from a series of solid tumours. J Natl Cancer Inst 51: 1417-1423
19. Haycock JW, Rowe SJ, Cartledge S, Wyatt A, Ghanem G, Morandini R, Rennie IG, Mac Neil S (2000) Melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocytes and melanoma cell lines. J Biol Chem 275: 15629-15636
20. Haycock JW, Wagner M, Morandini R, Ghanem G, Rennie IG, Mac Neil S (1999) Melanocyte stimulating hormone inhibits NF-κB activation in human melanocytes and melanoma cells. J Invest Dermatol 113: 560-566
21. Hedley SJ, Gawkrodger DJ, Weetman AP, Mac Neil S (1998a) MSH and melanogenesis in normal human adult melanocytes. Pigment Cell Res 11: 45-56
22. Hedley SJ, Gawkrodger DJ, Weetman AP, Morandini R, Boeynaems J-M, Ghanem G, Mac Neil (1998b) Melanocyte stimulating hormone inhibits tumour necrosis factor-α stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. Br J Dermatol 138: 536-543
23. Hedley SJ, Layton C, Heaton M, Chakrabarty KH, Dawson RA, Gawkrodger DJ, Mac Neil S (2002) Fibroblasts play a regulatory role in the control of pigmentation in reconstructed human skin from skin types I and II. Pigment Cell Res 15: 49-56
24. Hedley SJ, Murray A, Sisley K, Ghanem G, Morandini R, Gawkrodger DJ, Mac Neil S (2000) Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro. Melanoma Res 10(4): 323-330
25. Hill SE, Rees RC, Mac Neil S (1990) A positive association between agonist-induced cyclic AMP production in vitro and metastatic potential in murine B16 melanoma and hamster fibrosarcoma. Clin Exp Metast 8(5): 461-474
26. 7 α-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J Cell Sci 107: 205-211
27. Ichii-Jones F, Lear JT, Heagerty AHM, Smith AG, Hutchinson PE, Osborne J, Bowers B, Jones PW, Davies E, Ollier WE, Thomson W, Yengi L, Bath J, Fryer AA, Strange RC (1998) Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol 111: 218-221
28. Jiménez-Cervantes C, Germer S, González P, Sánchez J, Sánchez CO, García-Borrón JC (2001) Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett 508: 44-48
29. Kameyama K, Vieira WD, Tsukamoto K, Law LW, Hearing V (1990) Differentiation and the tumourigenic and metastatic phenotype of murine melanoma cells. Int J Cancer 45(6): 1151-1158
30. Kippenberger S, Bernd A, Loitsch S, Ramirez-Bosca A, Bereiter-Hahn J, Holzmann H (1995) MSH is expressed in cultured human melanocytes and keratinocytes. Eur J Dermatol 5: 395-397
31. Kozlowski JM, Hart IR, Fidler IJ, Hanna N (1984) A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst 72(4): 913-917
32. Lambert DT, Lerner AB (1983) Optimisation of a melanotropin-receptor binding assay by reversed-phase high-performance liquid chromatography. J Chromatogr 266: 567-576
33. Lerner AB, McGuire JS (1961) Effect of α-and β-melanocyte stimulating hormones on skin colour of man. Nature 21: 176-179
34. Lipton JM, Catania A (1997) Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today 18(3): 140-145
35. Liu PY, Johansson O (1995) Immunohistochemical evidence of alpha-, beta-and gamma-3 melanocyte stimulating hormone expression in cutaneous malignant melanoma of nodular type. J Dermatol Sci 10(3): 203-212
36. Luger TA, Schwarz T, Kalden H, Scholzen T, Schwarz A, Brzoska T (1999), Role of epidermal cell-derived α-MSH in ultraviolet light mediated local immunosuppression. In Cutaneous Neuroimmunomodulation; The Proopiomelanocortin System. Luger TA, Paus R, Lipton JM, Slominski AT (eds) pp 209-216. New York: The New York Academy of Sciences
37. Lunec J, Pieron C, Bal W, Mac Neil S, Thody AJ (1993) MSH receptors and function in amelanotic B16 melanoma cells. Melanoma Res 3: 99-106
38. Mac Neil S, Walker SW, Senior HJ, Pollock A, Brown BL, Bleehen SS, Munro DS, Tomlinson S (1984) Calmodulin activation of adenylate cyclase in the mouse B16 melanoma. Biochem J 224: 453-460
39. Metcalfe RA, Findlay C, Robertson WR, Weetman AP, MacNeil S (1998) Differential effect of thyroid-stimulating hormone (TSH) on intracellular free calcium and cAMP in cells transfected with the human TSH receptor. J Endocrinol 157: 415-424
40. Morandini R, Boeynaems JM, Hedley SJ, Mac Neil S, Ghanem G (1998) Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes. J Cell Physiol 175: 276-282
41. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257(5074): 1248-1251
42. Moustafa M, Szabo M, Ghanem G, Morandini R, Kemp EH, Mac Neil S, Haycock JW (2002) Inhibition of TNF-α stimulated NF-κB/p65 in human keratinocytes by α-melanocyte stimulating hormone and adrenocorticotrpic hormone peptides. J Invest Dermatol 119(6): 1244-1253
43. Murata J, Ayukawa K, Ogasawara M, Fujii H, Saiki I (1997) Melanocyte stimulating hormone blocks invasion of reconstituted basement membrane (matrigel) by murine B16 melanoma cells. Invas Metast 17: 82-93
44. Richardson B, Price A, Wagner M, Williams V, Lorigan P, Browne S, Miller JG, Mac Neil S (1999) Investigation of female survival benefit in metastatic melanoma. Br J Cancer 80(12): 2025-2033
45. Robinson SJ, Healy E (2002) Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 21(52): 8037-8046
46. Schauer E, Trautinger F, Kock A, Schwarz A, Bhardwaj R, Simon M, Ansel JC, Schwarz T, Luger TA (1994) Proopiomelanocortin-derived peptides are synthesised and released by human kerationcytes. J Clin Invest 93(5): 2258-2262
47. Schiöth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JES, Rees JL (1999) Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 260: 488-491
48. Sharma SD, Jiang J, Hadley ME, Bentley DL, Hruby VJ (1996) Melanotropic peptide-conjugated beads for microscopic visualisation and characterisation of melanoma melanotropin receptors. Proc Natl Acad Sci USA 93: 13715-13720
49. Sheppard JR, Koestler TP, Corwin S, Buscarino C, Doll J, Lester B, Greig RG, Poste G (1984) Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones. Nature 308: 544-547
50. Sheppard JR, Lester B, Doll J, Buscarino C, Gonzales E, Corwin S, Greig R, Poste G (1986) Biochemical regulation of adenylate cyclase in murine melanoma clones with different metastatic properties. Int J Cancer 37: 713-722
51. Siegrist W, Solca F, Stutz S, Giuffre L, Carrel S, Girard J, Eberle AN (1989) Characterisation of receptors for alpha-melanocyte stimulating hormone on human melanoma cells. Cancer Res 49: 6352-6358
52. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11: 328-330
53. Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A (2000) New aspects on the melanocortins and their receptors. Pharm Res 42: 393-420
54. Xia Y, Skoog V, Muceniece R, Chhajlani V, Wikberg JE (1995) Polyclonal antibodies against human melanocortin MC1 receptor: preliminary immunohistochemical localisation of melanocortin MC1 receptor to malignant melanoma cells. Eur J Pharmacol 288(3): 277-283
55. Zhu N, Eves PC, Katerinaki E, Szabo M, Morandini R, Ghanem G, Lorigan P, Mac Neil S, Haycock JW (2002) Melanoma cell attachment, invasion, and integrin expression is upregulated by tumour necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone. J Invest Dermatol 119(5): 1165-1171